secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silence Therapeutics plc (SLN)
CIK:        0001479615
Form:       8-K
Filed at:   2026-06-23T20:35:22+00:00
Accession:  0001193125-26-279577
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Silence Therapeutics issues updated corporate presentation on June 23, 2026
---------------------------------------------------------------------------

- Updated corporate presentation posted to investor section of company website.
- Presentation contains business updates but no specific financial or clinical data disclosed.
- Filing under Item 7.01; presentation furnished as Exhibit 99.1.
- No material new information provided in the 8-K itself.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479615/000119312526279577/0001193125-26-279577-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479615/000119312526279577/sln-20260623.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-279577

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer